Announcement on the Approval Reply from the China Securities Regulatory Commission for the Company's Application for Issuing Shares to Specific Objects via Simplified Procedures in 2025

Jinhe Biotechnology Co., Ltd.·August 7, 2026·1 page

✨ AI Summary

The company has received approval from the China Securities Regulatory Commission for its application to issue shares to specific objects via simplified procedures. The company must strictly follow the submitted application documents and issuance plan, complete the share issuance payment within ten working days, and report any major matters to the Shenzhen Stock Exchange.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 002688

Securities Abbreviation: Jinhe Bio

Announcement No.: 2026-070

Jinhe Bio-Tech Co., Ltd.

Announcement on the Approval Reply from the China Securities Regulatory Commission for the Company's Application for Issuing Shares to Specific Objects via Simplified Procedures in 2025

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed in this announcement and are jointly and severally liable for any false representations, misleading statements, or material omissions contained herein.

Jinhe Bio-Tech Co., Ltd. (h

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.